Standout Papers
Citation Impact
Citing Papers
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease
2007
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
2004 StandoutScience
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Rapamycin Inhibits the Generation of Graft-Versus-Host Disease- and Graft-Versus-Leukemia-Causing T Cells by Interfering with the Production of Th1 or Th1 Cytotoxic Cytokines
1998
Effects of professional oral health care on reducing the risk of chemotherapy-induced oral mucositis
2014
Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update
2012
The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy
2014
Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process
2012
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
2013
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection
2016
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines
2019
Idiopathic pulmonary fibrosis
2017 Standout
Osteoporosis
2019 Standout
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
2012
Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients
2001
Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients
2013
Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines
2019
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines
2020
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis
2005
The gene expression sequence of radiated mucosa in an animal mucositis model
2002
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Sjögren's syndrome
2005 Standout
Probiotic Effects on 5-Fluorouracil-Induced Mucositis Assessed by the Sucrose Breath Test in Rats
2007
Wearable biosensors for healthcare monitoring
2019 Standout
Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy
2006
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients
2013
Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy
2012
Systematic review of natural agents for the management of oral mucositis in cancer patients
2013
Acute graft-vs-host disease
2001
Apoptosis by Death Factor
1997 Standout
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer
2006
Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines
2019
Head and neck cancer
2008 Standout
Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?
2004
Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods
2019
Amifostine in clinical oncology: current use and future applications
2002
Systematic review of amifostine for the management of oral mucositis in cancer patients
2012
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
2004
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients
2016
A quantitative histometric murine in vivo model of radiation-induced oral mucositis
1998
Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy
1990
Toxicity in head and neck cancer: a review of trends and issues
2000
Antimicrobial therapy to prevent or treat oral mucositis
2003
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
2004
Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines
2019
Effects of low‐level laser therapy on collagen expression and neutrophil infiltrate in 5‐fluorouracil‐induced oral mucositis in hamsters
2010
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
2016 Standout
Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies
2006
Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma
2005
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Systematic review of basic oral care for the management of oral mucositis in cancer patients
2013
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients
2012
Chronic oral mucositis after radiotherapy to the head and neck: a new insight
2016
Emerging evidence on the pathobiology of mucositis
2013
Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host
2011
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Transglutaminases: crosslinking enzymes with pleiotropic functions
2003 Standout
Nasopharyngeal carcinoma
2015 Standout
Graft-versus-host disease
2009 Standout
Gingival health and salivary function in head and neck-irradiated patients
1992
The pathobiology of mucositis
2004 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review
2019
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Pathophysiology of Graft-Versus-Host Disease
2006
Management of the febrile neutropenic cancer patient: lessons from 40 years of study
2005
Hematopoietic Stem-Cell Transplantation
2006 Standout
TRPC1 Ca2+-Permeable Channels in Animal Cells
2007
Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications
2001
Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer
2015
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
Resolution of Bisphosphonate-Associated Osteonecrosis of the Mandible: Possible Application for Intermittent Low-Dose Parathyroid Hormone [rhPTH(1-34)]
2007
Chemotherapy Treatment in Pediatric Patients with Acute Myeloid Leukemia Receiving Antimicrobial Prophylaxis Leads to a Relative Increase of Colonization with Potentially Pathogenic Bacteria in the Gut
2009
Late effects of radiation therapy in the head and neck region
1995
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
2004
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines
2011
Idiopathic Pulmonary Fibrosis
2001 Standout
Mucositis
2015
Periodontal disease and periodontal management in patients with cancer
2001
The diagnostic uses of saliva
1990
Oral health care for the cancer patient
1996
Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
2009
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients
2012
Major salivary gland function in patients with radiation-induced xerostomia: Flow rates and sialochemistry
1993
Autophagy in cell death: an innocent convict?
2005 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Essential Role of theCandida albicansTransglutaminase Substrate, Hyphal Wall Protein 1, in Lethal Oroesophageal Candidiasis in Immunodeficient Mice
2002
The burdens of cancer therapy
2003
5-Fluorouracil induces autophagic degeneration in rat oral keratinocytes
2001
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity
1998
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
2013 StandoutNature
Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment
2003
The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: A double-blind placebo-controlled prospective Phase III study by Radiation Therapy Oncology Group 9901
2007
A Psychometric Toolbox for Testing Validity and Reliability
2007 Standout
Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-fluorouracil-induced oral mucositis in hamsters: evaluation of two low-intensity laser protocols
2009
Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines
2019
Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model
2015
Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study
2001
Childhood acute lymphoblastic leukemia
2002
Intestinal mucositis: mechanisms and management
2007
The TRPV4 Channel Contributes to Intercellular Junction Formation in Keratinocytes
2010
TRPV3 regulates nitric oxide synthase-independent nitric oxide synthesis in the skin
2011 StandoutNobel
Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients
2013
Head and Neck Cancer
2001 Standout
Acute Lymphoblastic Leukemia
2004
NCCN Task Force Report: Prevention and Management of Mucositis in Cancer Care
2008
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
SALIVARY AND ORAL COMPONENTS OF SJÖGREN’S SYNDROME
1992
Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment
2001
The Diagnostic Applications of Saliva — A Review
2002
Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD
2007
Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study
2011
Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation
1996
The pathophysiology and treatment of graft-versus-host disease
1983
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Acute Airway Obstruction Due to Necrotizing Tracheobronchial Aspergillosis in Immunocompromised Patients: A New Clinical Entity
1989
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis.
2003
Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience
1985 StandoutNobel
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
2013
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation
2000
BONE MARROW TRANSPLANTATION: A REVIEW OF DELAYED COMPLICATIONS
1984 StandoutNobel
Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning
2005
Bone Marrow Transplant
1990 Standout
Parotid gland pathophysiology after mixed gamma and neutron irradiation of cancer patients
1981
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications
2014
Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector
2007
Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
1999
Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease.
1996
Oral complications of cancer therapy.
2002
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance])
2014
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
A general synthesis of diversely substituted indazoles and hetero-aromatic derivatives from o-halo-(het)arylaldehydes or -phenones
2014
Prevention and Treatment of the Consequences of Head and Neck Radiotherapy
2003
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Multiple Myeloma
2011 Standout
TLR Signaling Modulates Side Effects of Anticancer Therapy in the Small Intestine
2015
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Review. Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization.
2007
Oral Sequelae of Head and Neck Radiotherapy
2003 Standout
Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial
2011
The Biologic Role for Nuclear Factor -Kappa B in Disease and its Potential Involvement in Mucosal Injury Associated with Anti-neoplastic Therapy
2002
B7 Expression on T Cells Down-Regulates Immune Responses through CTLA-4 Ligation via R-T Interactions
2004 StandoutNobel
Host Dendritic Cells Alone Are Sufficient to Initiate Acute Graft-versus-Host Disease
2004
Works of Mark M. Schubert being referenced
Gynecological abnormalities following allogeneic bone marrow transplantation.
1990
Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation development of an oral mucositis index
1992
Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients
2012
Oral infections due to Cytomegalovirus in immunocompromised patients
1993
Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy
1999
Oral mucositis in myelosuppressive cancer therapy
1999
Management of orofacial pain in cancer patients
1993
Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice
2006
Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients
1995
Amifostine in the management of radiation-induced and chemo-induced mucositis
2006
The 20 Item Oral Mucositis Index: Reliability and Validity in Bone Marrow and Stem Cell Transplant Patients
2002
Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls
2006
Pilot Trial of Cytoprotection With Amifostine Given With High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation
2000
Bisphosphonate‐associated osteonecrosis of mandibular and maxillary bone
2005
Anti-inflammatory agents in the management of alimentary mucositis
2006
Evidence that TRPC1 contributes to calcium-induced differentiation of human keratinocytes
2005
Oral Graft-Versus-Host Disease
2008
A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation
2007
Early oral changes following bone marrow transplantation
1988
Low-energy He/Ne laser in the prevention of radiation-induced mucositis
1999
Updated clinical practice guidelines for the prevention and treatment of mucositis
2007
Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management itioning/immune suppression to initial engraftment
2000
A TOXICITY STUDY OF TRIMETREXATE USED IN COMBINATION WITH CYCLOSPORINE AS ACUTE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN HLA-MISMATCHED, RELATED DONOR BONE MARROW TRANSPLANTS
1995
Alimentary mucositis: putting the guidelines into practice
2006
Molecular Identification of an Invasive Gingival Bacterial Community
2005
Benzydamine HCl for prophylaxis of radiation-induced oral mucositis
2001
Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature
1986 StandoutNobel
Predictors of Oral Mucositis in Patients Receiving Hematopoietic Cell Transplants for Chronic Myelogenous Leukemia
2004
Iatrogenic Causes of Salivary Gland Dysfunction
1987
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism
2001
Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management.
2003
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
2001
Whole saliva albumin as an indicator of stomatitis in cancer therapy patients
1981
Graft-vs.-Host Disease
1997
DISORDERED SALIVARY IMMUNOGLOBULIN SECRETION AND SODIUM TRANSPORT IN HUMAN CHRONIC GRAFT-VERSUS-HOST DISEASE
1983
Oral and ophthalmic pathology of graft versus host disease in man: Predictive value of the lip biopsy
1981
The use of benzydamine HCl for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study.
1987
Oral manifestations of chronic graft-v-host disease
1984
Iatrogenic Causes of Salivary Gland Dysfunction
1987